Informa (LON:INF) had its target price dropped by equities researchers at Barclays from GBX 940 ($12.24) to GBX 885 ($11.53) in a research report issued to clients and investors on Friday. The brokerage currently has an “overweight” rating on the stock. Barclays’ price objective points to a potential upside of 16.17% from the stock’s previous close.
Other research analysts have also recently issued research reports about the stock. Peel Hunt reiterated a “hold” rating on shares of Informa in a research note on Tuesday, July 3rd. Liberum Capital reiterated a “buy” rating on shares of Informa in a research note on Wednesday, July 25th. Deutsche Bank reiterated a “buy” rating on shares of Informa in a research note on Thursday, July 26th. Shore Capital reiterated a “buy” rating on shares of Informa in a research note on Monday, August 13th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 900 ($11.72) target price on shares of Informa in a research note on Wednesday, August 1st. Five investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of GBX 862.42 ($11.23).
LON:INF opened at GBX 761.80 ($9.92) on Friday. Informa has a 1 year low of GBX 624.50 ($8.13) and a 1 year high of GBX 773 ($10.07).
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Featured Story: Diversification For Individual Investors
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.